These data suggest that Tm4sf19 may play an essential role in crosstalk between bone cells and immune cells, indicating that Tm4sf19 may be a novel therapeutic target for inflammatory bone diseases. This evidence concerns the gene TM4SF19 and bone inflammation disease.